Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets
Frontiers in Pharmacology · 29.08.2025 · 16
DOI: 10.3389/fphar.2025.1578342 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.08.2025. Verfasst von Ruixian Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine and Targeted Tracer Research and Development Laboratory and State Key Laboratory of Biotherapy a…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 298 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer is now the most common malignancy among females. Numerous highly effective small-molecule inhibitors, such as tamoxifen and fulvestrant, have received clinical approval, significantly enhancing the therapeutic landscape of breast cancer. However, the emergence of drug resistance in some patients presents an unmet clinical need. Identifying resistance-related targets has been a key therapeutic strategy in combating drug-resistant tumors. Studies investigating the molecular characteristics and resistance mechanisms of breast cancer have unveiled novel targets, including cell cycle checkpoint molecules, breast cancer stem cell-related molecules, and anti-apoptotic proteins. Relevant small-molecule inhibitors have shown promising potential in overcoming drug-resistant breast cancer in both preclinical and clinical trials. In this review, we evaluate the resistance mechanisms of available targeted inhibitors for breast cancer and summarize innovative targeted strategies with the potential to overcome resistance, guided by clinical research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine and Targeted Tracer Research and Development Laboratory and State Key Laboratory of Biotherapy and Cancer Center and Department of General Surgery and Breast Center/N…
- General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Chen, R., Zhou, Z., Meng, X., Lei, Y., Wang, Y., & Wang, Y. (2025). Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1578342
Vancouver
Chen R, Zhou Z, Meng X, Lei Y, Wang Y, Wang Y. Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1578342
BibTeX
@article{Chen2025,
author = {Chen, Ruixian and Zhou, Zhilan and Meng, Xiangyue and Lei, Yi and Wang, Yuxi and Wang, Yanyan},
title = {Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1578342}
}
EUVIMED